Hiv protease inhibitors

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

PI

Definition
This section has been translated automatically.

Group of protease inhibitors that inhibit the viral protease of HI viruses and are used for the treatment of HIV infections.

Pharmacodynamics (Effect)
This section has been translated automatically.

HIV protease is an enzyme that plays an essential role in the genesis of new HI viruses. The HIV protease catalyses the cleavage of precursor molecules, which is a prerequisite for the reproduction and spread of the HI virus. HIV protease inhibitors (see also protease inhibitors in general) are modelled on the viral protease and differ only minimally from their models in certain amino acid sequences. The inhibitors occupy the protease binding site on the substrate (precursor protein) and thus interfere with the further processes in protein formation. As a result, incorrect virus components are generated, which leads to an interruption of the replication cycle.

Indication
This section has been translated automatically.

Therapy of HIV infections; preparations are prescribed in combination with other antiretroviral drugs (see below HAART).

Undesirable effects
This section has been translated automatically.

S.u. HAART.

Literature
This section has been translated automatically.

  1. Eron JJ JR (2002) HIV-1 protease inhibitors. Clin Infect Dis 30: 160-170

Authors

Last updated on: 29.10.2020